Literature DB >> 10467129

Interactions of (-)-ilimaquinone with methylation enzymes: implications for vesicular-mediated secretion.

H S Radeke1, C A Digits, R L Casaubon, M L Snapper.   

Abstract

BACKGROUND: The marine sponge metabolite (-)-ilimaquinone has antimicrobial, anti-HIV, anti-inflammatory and antimitotic activities, inhibits the cytotoxicity of ricin and diptheria toxin, and selectively fragments the Golgi apparatus. The range of activities demonstrated by this natural product provides a unique opportunity for studying these cellular processes.
RESULTS: Affinity chromatography experiments show that (-)-ilimaquinone interacts with enzymes of the activated methyl cycle: S-adenosylmethionine synthetase, S-adenosylhomocysteinase and methyl transferases. Known inhibitors of these enzymes were found to block vesicle-mediated secretion in a manner similar to (-)-ilimaquinone. Moreover, the antisecretory effects of (-)-ilimaquinone and inhibitors of methylation chemistry, but not brefeldin A, could be reversed in the presence of the cellular methylating agent S-adenosylmethionine. Of the enzymes examined in the activated methyl cycle, S-adenosylhomocysteinase was specifically inhibited by (-)-ilimaquinone. Consistent with these observations, (-)-ilimaquinone was shown to obstruct new methylation events in adrenocorticotrophic hormone (ACTH)-secreting pituitary cells.
CONCLUSIONS: (-)-ilimaquinone inhibits cellular methylations through its interactions with S-adenosylhomocysteinase. Furthermore, these studies indicate that the inhibition of secretion by ilimaquinone is the result of the natural product's antimethylation activity. It is likely that the ability to fragment the Golgi apparatus, as well as other activities, are also related to ilimaquinone's influence on methylation chemistry.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10467129     DOI: 10.1016/s1074-5521(99)80115-x

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  11 in total

1.  Organellar proteomics reveals Golgi arginine dimethylation.

Authors:  Christine C Wu; Michael J MacCoss; Gonzalo Mardones; Claire Finnigan; Soren Mogelsvang; John R Yates; Kathryn E Howell
Journal:  Mol Biol Cell       Date:  2004-03-26       Impact factor: 4.138

2.  Trifunctional norrisolide probes for the study of Golgi vesiculation.

Authors:  Gianni Guizzunti; Thomas P Brady; Vivek Malhotra; Emmanuel A Theodorakis
Journal:  Bioorg Med Chem Lett       Date:  2006-11-06       Impact factor: 2.823

3.  Golgi-modifying properties of macfarlandin E and the synthesis and evaluation of its 2,7-dioxabicyclo[3.2.1]octan-3-one core.

Authors:  Martin J Schnermann; Christopher M Beaudry; Anastasia V Egorova; Roman S Polishchuk; Christine Sütterlin; Larry E Overman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-23       Impact factor: 11.205

Review 4.  Marine-derived metabolites of S-adenosylmethionine as templates for new anti-infectives.

Authors:  Janice R Sufrin; Steven Finckbeiner; Colin M Oliver
Journal:  Mar Drugs       Date:  2009-08-26       Impact factor: 5.118

Review 5.  Reactivity and biological activity of the marine sesquiterpene hydroquinone avarol and related compounds from sponges of the order Dictyoceratida.

Authors:  Dusan Sladić; Miroslav J Gasić
Journal:  Molecules       Date:  2006-01-31       Impact factor: 4.411

6.  Inducers of hypoxic response: marine sesquiterpene quinones activate HIF-1.

Authors:  Lin Du; Yu-Dong Zhou; Dale G Nagle
Journal:  J Nat Prod       Date:  2013-06-03       Impact factor: 4.050

7.  Comparison of the biological properties of several marine sponge-derived sesquiterpenoid quinones.

Authors:  Cherie A Motti; Marie-Lise Bourguet-Kondracki; Arlette Longeon; Jason R Doyle; Lyndon E Llewellyn; Dianne M Tapiolas; Ping Yin
Journal:  Molecules       Date:  2007-07-11       Impact factor: 4.411

Review 8.  Inhibitors of the cellular trafficking of ricin.

Authors:  Julien Barbier; Céline Bouclier; Ludger Johannes; Daniel Gillet
Journal:  Toxins (Basel)       Date:  2012-01-06       Impact factor: 4.546

9.  The tumor suppressor RhoBTB1 controls Golgi integrity and breast cancer cell invasion through METTL7B.

Authors:  Caroline M McKinnon; Harry Mellor
Journal:  BMC Cancer       Date:  2017-02-20       Impact factor: 4.430

10.  Ilimaquinone and ethylsmenoquinone, marine sponge metabolites, suppress the proliferation of multiple myeloma cells by down-regulating the level of β-catenin.

Authors:  Seoyoung Park; Eunju Yun; In Hyun Hwang; Soojin Yoon; Dong-Eun Kim; Ji Seon Kim; MinKyun Na; Gyu-Yong Song; Sangtaek Oh
Journal:  Mar Drugs       Date:  2014-05-28       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.